Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.
复制标题
DOI:
10.1038/s41467-021-21588-4
复制
发表时间:
2021-02-26
影响因子:
16.6
通讯作者:
Lindsley RC
中科院分区:
文献类型:
--
作者:
Kennedy AL;Myers KC;Bowman J;Gibson CJ;Camarda ND;Furutani E;Muscato GM;Klein RH;Ballotti K;Liu S;Harris CE;Galvin A;Malsch M;Dale D;Gansner JM;Nakano TA;Bertuch A;Vlachos A;Lipton JM;Castillo P;Connelly J;Churpek J;Edwards JR;Hijiya N;Ho RH;Hofmann I;Huang JN;Keel S;Lamble A;Lau BW;Norkin M;Stieglitz E;Stock W;Walkovich K;Boettcher S;Brendel C;Fleming MD;Davies SM;Weller EA;Bahl C;Carter SL;Shimamura A;Lindsley RC
To understand the mechanisms that mediate germline genetic leukemia predisposition, we studied the inherited ribosomopathy Shwachman-Diamond syndrome (SDS), a bone marrow failure disorder with high risk of myeloid malignancies at an early age. To define the mechanistic basis of clonal hematopoiesis in SDS, we investigate somatic mutations acquired by patients with SDS followed longitudinally. Here we report that multiple independent somatic hematopoietic clones arise early in life, most commonly harboring heterozygous mutations in EIF6 or TP53. We show that germline SBDS deficiency establishes a fitness constraint that drives selection of somatic clones via two distinct mechanisms with different clinical consequences. EIF6 inactivation mediates a compensatory pathway with limited leukemic potential by ameliorating the underlying SDS ribosome defect and enhancing clone fitness. TP53 mutations define a maladaptive pathway with enhanced leukemic potential by inactivating tumor suppressor checkpoints without correcting the ribosome defect. Subsequent development of leukemia was associated with acquisition of biallelic TP53 alterations. These results mechanistically link leukemia predisposition to germline genetic constraints on cellular fitness, and provide a rational framework for clinical surveillance strategies. Understanding the molecular basis of leukaemia predisposition is essential for intervention. The authors here investigate germline genetic leukaemia predisposition by studying Shwachman-Diamond syndrome and report compensatory inactivating mutations in EIF6 and transforming biallelic TP53 alterations.
登录
查看更多内容
影响因子:
82.9
作者:
Bernard E;Nannya Y;Hasserjian RP;Devlin SM;Tuechler H;Medina-Martinez JS;Yoshizato T;Shiozawa Y;Saiki R;Malcovati L;Levine MF;Arango JE;Zhou Y;Solé F;Cargo CA;Haase D;Creignou M;Germing U;Zhang Y;Gundem G;Sarian A;van de Loosdrecht AA;Jädersten M;Tobiasson M;Kosmider O;Follo MY;Thol F;Pinheiro RF;Santini V;Kotsianidis I;Boultwood J;Santos FPS;Schanz J;Kasahara S;Ishikawa T;Tsurumi H;Takaori-Kondo A;Kiguchi T;Polprasert C;Bennett JM;Klimek VM;Savona MR;Belickova M;Ganster C;Palomo L;Sanz G;Ades L;Della Porta MG;Elias HK;Smith AG;Werner Y;Patel M;Viale A;Vanness K;Neuberg DS;Stevenson KE;Menghrajani K;Bolton KL;Fenaux P;Pellagatti A;Platzbecker U;Heuser M;Valent P;Chiba S;Miyazaki Y;Finelli C;Voso MT;Shih LY;Fontenay M;Jansen JH;Cervera J;Atsuta Y;Gattermann N;Ebert BL;Bejar R;Greenberg PL;Cazzola M;Hellström-Lindberg E;Ogawa S;Papaemmanuil E
通讯作者:
Papaemmanuil E
DOI:
10.1056/nejmoa1409405
发表时间:
2014-12-25
期刊:
The New England journal of medicine
影响因子:
--
作者:
Genovese G;Kähler AK;Handsaker RE;Lindberg J;Rose SA;Bakhoum SF;Chambert K;Mick E;Neale BM;Fromer M;Purcell SM;Svantesson O;Landén M;Höglund M;Lehmann S;Gabriel SB;Moran JL;Lander ES;Sullivan PF;Sklar P;Grönberg H;Hultman CM;McCarroll SA
通讯作者:
McCarroll SA
影响因子:
3.3
作者:
Barlow, Kyle A.;Conchuir, Shane O.;Kortemme, Tanja
通讯作者:
Kortemme, Tanja
影响因子:
20.3
作者:
Austin, KM;Leary, RJ;Shimamura, A
通讯作者:
Shimamura, A
影响因子:
30.8
作者:
通讯作者:
--